事業提携・ライセンシング・投資・M&A動向:July 2013(製薬業界)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends for July 2013 in Pharmaceuticals

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 7
1.2 List of Figures 10
2 Pharmaceuticals & Healthcare, Global, Deal Summary 13
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, July 2013 13
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, July 2013 15
2.2.1 Loblaw to Acquire Shoppers Drug Mart for US$11.93 Billion 15
2.2.2 Community Health Systems to Acquire Health Management Associates for Up to US$7.6 Billion 17
2.2.3 Acetylon Pharma Enters into Co-Development Agreement with Celgene 18
2.2.4 Cubist Pharma to Acquire Trius Therapeutics for Up to US$818 Million 19
2.2.5 Envision Healthcare Announces IPO of Shares for Up to US$805 Million 20
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, July 2013 21
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, July 2013 22
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 23
3.1 Pharmaceuticals & Healthcare, Global, M&A, July 2013 23
3.1.1 Top M&A Deals in July 2013 24
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, February 2013 – July 2013 25
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, July 2013 27
3.2.1 Top Equity Offering Deals in July 2013 28
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, February 2013 – July 2013 29
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, July 2013 31
3.3.1 Top PE/VC Deals in July 2013 32
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, July 2013 33
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, July 2013 34
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, February 2013–July 2013 36
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, February 2013–July 2013 37
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, July 2013 38
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, July 2013 38
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, February 2013 – July 2013 40
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), July 2013 42
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, July 2013 43
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), February 2013 – July 2013 44
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, February 2013 – July 2013 46
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), February 2013 – July 2013 47
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), February 2013 – July 2013 49
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, July 2013 51
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, July 2013 51
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2013 53
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, July 2013 54
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, July 2013 55
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, July 2013 56
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), February 2013 – July 2013 57
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), February 2013 – July 2013 59
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), February 2013 – July 2013 61
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), February 2013 – July 2013 63
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 65
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, July 2013 65
6.1.1 Oncology – Deals of the Month 67
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, July 2013 68
6.2.1 Central Nervous System – Deals of the Month 69
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, July 2013 71
6.3.1 Immunology – Deal of the Month 72
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, July 2013 74
6.4.1 Infectious Diseases – Deals of the Month 75
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, July 2013 77
6.5.1 Metabolic Disorders – Deals of the Month 79
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, July 2013 80
6.6.1 Cardiovascular – Deal of the Month 81
6.7 Pharmaceuticals & Healthcare, Global, Dermatology, Deals, July 2013 82
6.7.1 Dermatology – Deal of the Month 83
7 Deal Summary by Geography 84
7.1 Pharmaceuticals & Healthcare, North America Deals, July 2013 84
7.1.1 North America – Deals of the Month 85
7.2 Pharmaceuticals & Healthcare, Europe, Deals, July 2013 87
7.2.1 Europe – Deals of the Month 88
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, July 2013 90
7.3.1 Asia-Pacific – Deals of the Month 91
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, July 2013 93
7.4.1 Rest of the World – Deals of the Month 94
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 96
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, February 2013 – July 2013 96
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, February 2013 – July 2013 98
9 Further Information 100
9.1 Methodology 100
9.2 About GlobalData 101
9.3 Disclosure information 102
9.4 Disclaimer 102


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向:July 2013(製薬業界)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for July 2013 in Pharmaceuticals
■ 発行日:2013年8月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161916
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。